Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Border Medical Oncology
Albury, New South Wales, Australia
Active, not recruiting - Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
Active, not recruiting - Townsville University Hospital
Townsville, Queensland, Australia
Active, not recruiting - St Vincent'S Hospital Melbourne
Fitzroy, Victoria, Australia
Active, not recruiting - Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia
Active, not recruiting
- Universitätsklinikum Leipzig
Leipzig, Saxony, Germany
Active, not recruiting - Charité Universitätsmedizin Berlin
Berlin, State of Berlin, Germany
Active, not recruiting
- Auckland City Hospital
Grafton, Auckland, New Zealand
Active, not recruiting
- Asan Medical Center
Seoul, Seoul, South Korea
Active, not recruiting - Samsung Medical Center
Seoul, Seoul, South Korea
Active, not recruiting - Seoul National University Hospital
Seoul, Seoul, South Korea
Completed - Kyungpook National University Hospital
Daegu, South Korea
Active, not recruiting - Pusan National University Hospital
Pusan, South Korea
Active, not recruiting - Seoul National University Bundang Hospital
Seongnam, South Korea
Active, not recruiting
- Hospital Universitario Vall D'Hebron
Barcelona, Barcelona, Spain
Active, not recruiting - Hospital Quirón Madrid
Pozuelo de Alarcón, Madrid, Spain
Active, not recruiting - Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, Spain
Active, not recruiting - Hospital Clinico Universitario de Valencia
Valencia, Valencia, Spain
Active, not recruiting - Hospital Universitari I Politècnic la Fe
Valencia, Valencia, Spain
Active, not recruiting
- the Kirklin Clinic of Uab Hospital
Birmingham, Alabama, United States
Recruiting - City of Hope Comprehensive Cancer Center
Duarte, California, United States
Active, not recruiting - University of California Irvine
Irvine, California, United States
Deepa Jeyakumar, MDRecruiting - Ucsd Moores Cancer Center
La Jolla, California, United States
Active, not recruiting - Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
Eric Tam, MDRecruiting - Stanford Cancer Center
Palo Alto, California, United States
Gabriel Mannis, MDRecruiting - University of California, Davis
Sacramento, California, United States
Recruiting - Yale University
New Haven, Connecticut, United States
Nikolai Podoltsev, MD, PhDRecruiting - University of Miami - Miller School of Medicine
Miami, Florida, United States
Recruiting - Emory University
Atlanta, Georgia, United States
Active, not recruiting - Massachusetts General Hospital
Boston, Massachusetts, United States
Active, not recruiting - Duke University Medical Center
Durham, North Carolina, United States
Recruiting - Cleveland Clinic - Taussig Cancer Center
Cleveland, Ohio, United States
Active, not recruiting - the Ohio State University Wexner Medical Center
Columbus, Ohio, United States
Uma Borate, MDRecruiting - Md Anderson Cancer Center
Huston, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Mar 2019
- Primary completion
- 30 Nov 2026
- Completion
- 30 Apr 2027
- Last update posted
- 26 Aug 2025
- Registered enrollment
- 240
- Registry id
- NCT03850574
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.